Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Cellectis, the French gene-editing company, has launched a $100m US capital raising to help fund its research and development operations. The sector has had a record year for issuance in 2020, as the Covid-19 pandemic has concentrated minds on global healthcare innovation. -
AirAsia X is looking to raise MR500m ($123m) from a rights issue and a placement of new stock to some shareholders.
-
Gore Street Energy Storage Fund, a UK energy storage infrastructure investor, has completed a £60m capital raise, to buy new energy storage projects.
-
Fugro, the Dutch geo-data specialist, has completed its €197m rights issue, a key proponent in a large refinancing package that resolves longstanding issues around debt maturity.
-
Nio has launched a US follow-on offering that could raise up to $2.71bn, becoming the third Chinese electric vehicle (EV) maker to tap the equity market in less than two weeks.
-
Aveva, the UK software company, has completed its £2.6bn rights issue to partially fund the acquisition of OSIsoft a US real-time data producer. The deal marks another success for M&A driven capital raises.
